Search

Your search keyword '"Barak LS"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Barak LS" Remove constraint Author: "Barak LS"
133 results on '"Barak LS"'

Search Results

1. PDGF-induced cell motility depends on EDG-1

4. Diffusion of low density lipoprotein-receptor complex on human fibroblasts

5. Design of allosteric modulators that change GPCR G protein subtype selectivity.

6. Nonlinear progression during the occult transition establishes cancer lethality.

7. β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in Rodents.

8. Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens.

9. Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.

10. Ghrelin receptor signaling in health and disease: a biased view.

11. Establishment of multi-stage intravenous self-administration paradigms in mice.

12. Discovery of a functionally selective ghrelin receptor (GHSR 1a ) ligand for modulating brain dopamine.

13. HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.

14. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.

15. β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

16. A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion.

17. Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.

18. Encoding the β-Arrestin Trafficking Fate of Ghrelin Receptor GHSR1a: C-Tail-Independent Molecular Determinants in GPCRs.

19. A Brief History of the β-Arrestins.

20. Ghrelin receptor antagonism of hyperlocomotion in cocaine-sensitized mice requires βarrestin-2.

21. Design, synthesis and biological evaluation of GPR55 agonists.

22. Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

23. Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness.

24. Probing the Allosteric Role of the α5 Subunit of α3β4α5 Nicotinic Acetylcholine Receptors by Functionally Selective Modulators and Ligands.

25. Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.

26. ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse.

27. Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

28. A rapid and affordable screening platform for membrane protein trafficking.

29. Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.

30. Lgr4 and Lgr5 drive the formation of long actin-rich cytoneme-like membrane protrusions.

31. Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.

32. Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2.

33. G Protein and β-arrestin signaling bias at the ghrelin receptor.

34. IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells.

35. Imidazole-derived agonists for the neurotensin 1 receptor.

36. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.

37. The stem cell-expressed receptor Lgr5 possesses canonical and functionally active molecular determinants critical to β-arrestin-2 recruitment.

38. Triphenylmethane dye activation of beta-arrestin.

39. Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.

40. Novel adamantyl cannabinoids as CB1 receptor probes.

41. Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network.

42. The intestinal glucose-apelin cycle controls carbohydrate absorption in mice.

43. Small molecule modulators of Wnt/β-catenin signaling.

44. Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling.

45. BRET biosensors to study GPCR biology, pharmacology, and signal transduction.

46. The insecticide synergist piperonyl butoxide inhibits hedgehog signaling: assessing chemical risks.

47. Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.

48. Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy.

49. Modeling of bias for the analysis of receptor signaling in biochemical systems.

50. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.

Catalog

Books, media, physical & digital resources